Combining Genetic Mutation and Expression Profiles Identifies Novel Prognostic Biomarkers of Lung Adenocarcinoma

MOTIVATION: Although several prognostic signatures for lung adenocarcinoma (LUAD) have been developed, they are mainly based on a single-omics data set. This article aims to develop a novel set of prognostic signatures by combining genetic mutation and expression profiles of LUAD patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yun, Liu, Fu, Hu, Xintong, He, Jiaxue, Jiang, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826273/
https://www.ncbi.nlm.nih.gov/pubmed/35153523
http://dx.doi.org/10.1177/1179554920966260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826273/
https://www.ncbi.nlm.nih.gov/pubmed/35153523
http://dx.doi.org/10.1177/1179554920966260

Ejemplares similares